Medicare will start covering obesity drugs for the first time. Here's what patients should know

Read full story on CNBC Markets
Share
Medicare will start covering obesity drugs for the first time. Here's what patients should know
AI disclosure

Summary

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.

Original reporting

Open original source

Related coverage

Read full article on CNBC Markets

Get the AFBytes Brief

Major stories, AI-assisted analysis, and what to watch next. Free, monthly, unsubscribe anytime.